Tuberculosis therapy in the Canton of Zurich 1991-1993;Tuberkulosetherapie im Kanton Zurich 1991-1993

Schweizerische Medizinische Wochenschrift

Volumn 126, Issue 48, 1996, Pages 2059-2067

  Rose, N ^a   Shang, H ^a   Pfyffer, G E ^b   Brandli O ^a  

^a Zürcher Höhenklinik Wald ^*  (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CAPREOMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; CLOFAZIMINE; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; OFLOXACIN; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN; RIFATER; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; CHILD; CONFERENCE PAPER; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIMARY MEDICAL CARE; SWITZERLAND; TUBERCULOSIS; AIDS RELATED COMPLEX; ARTICLE; CASE REPORT; COHORT ANALYSIS; DRUG COMBINATION; DRUG RESISTANCE; MIDDLE AGED; PATIENT COMPLIANCE; RECURRENT DISEASE; RETROSPECTIVE STUDY; TREATMENT FAILURE;

ADOLESCENT; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; COHORT STUDIES; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT FAILURE; TUBERCULOSIS;

EID: 0030607554     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. British Thoracic Society: A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. Br J Dis Chest 1984; 78: 330-336.
2. Snider DE, Graczyk J, Bek E, Rogowski J: Supervised six-months treatment of newly diagnosed pulmonary tuberculosis using Isoniazid, Rifampin, and Pyrazinamide, with and without Streptomycin. Am Rev Respir Dis 1984; 130: 1091-1094.
3. Roussel G: Résultats lointains d'un essai de chimiothérapie de courte durée. Rev Fr Mal Resp 1983; 11: 847-857.
4. Combs DL, O'Brien RJ, Geiter L: USPHA Tuberculosis short-course chemotherapy trial 21: effectiveness, toxicity and acceptability. Ann Intern Med 1990; 112: 397-406.
5. Kamolratanakul P, Chunhaswasdikul B, Jittinandana A, Tangsharoensathien V, Udomrati N et al.: Cost-effectiveness analysis of three short-course anti-tuberculosis programmes compared with a standard regimen in Thailand. J Clin Epidemiol 1993; 46: 631-636.
6. Omerod L, McCarthy O, Rudd R, Horsfield N: Short course chemotherapy for pulmonary tuberculosis. Resp Med 1991; 85: 291-294.
7. Brändli O, Haegi V, Villiger B, Bohn W, Baumann HR, Zäch R: Die Kurzzeittherapie der Lungentuberkulose mit einer fixen Kombination von Isoniazid, Rifampicin und Pyrazinamid. Schweiz Med Wochenschr 1989; 119: 299-305.
8. WHO: WHO Tuberculosis Programme. Framework for effective tuberculosis control. WHO/TB/94.179.
9. Payk TR: Checkliste Psychiatrie. Stuttgart: Thieme, 1992: 294.
10. Coulon P, Zellweger JP: Outcome of patients treated for pulmonary TB in Vaud county. Tuber Lung Dis 1995; 76: 79-80.
11. Rothe TB, Karrer W: Short-course therapy of pulmonary tuberculosis: doctor's compliance. Tuber Lung Dis 1996; 77: 93-97.
12. Pfyffer GE: Tuberkulose: Diagnostik und Resistenzhäufigkeit 1991/92. Schweiz Rundsch Med Prax 1993; 82: 1090-1095.
13. Gusset T, Rieder HL, Salfinger M: Incidence of resistance of tuberculosis bacteria in Switzerland. Schweiz Rundsch Med Prax 1993; 82: 1101-1104.
14. Borchardt J, Kirsten D, Jörres R, Kroeger C, Magnussen H: Resistenzhäufigkeit und Risikofaktoren für die Resistenz bei Mycobakterium tuberculosis. Pneumologie 1996; 50: 28-35.
15. Weis S, Slocum P, Blais F, King B, Nunn M et al.: The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med 1994; 330: 17.
16. Manalo F, Tan F, Saarbaro J, Iseman M: Community based short-course treatment of pulmonary tuberculosis in a developing nation. Initial report of an eight-month, largely intermittent regimen in a population with a high prevalence of drug resistance. Am Rev Respir Dis 1990; 142: 1301-1305.
17. American Thoracic Society: Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 1994; 149: 1359-1374.
18. Frieden TR, Sterling T, Pablos-Mendez A, Kilburn JO, Canthen GM et al.: The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 1993; 328: 521-526.
19. Schaberg T, Gloger G, Reichert B, Mauch H, Lode H: Resistente Lungentuberkulose in Berlin 1987-1993. Pneumologie 1996; 50: 21-27.
20. Schweizerische Vereinigung gegen Tuberkulose und Lungenkrankheiten: Richtlinien für die Behandlung der Tuberkulose. Bull BAG 1996; 16: 9-13.
21. Small P, Schecter F, Goodman P, Sande M, Chaisson R, Hopewell P: Treatment of tuberculosis in patients with advanced HIV infection. N Engl J Med 1991; 324: 289.
22. Sumartojo E: When tuberculosis treatment fails. Am Rev Respir Dis 1993; 147: 1311-1320.